Microbicides 2004

Microbicides 2004

Microbicides 200428-31 March 2004, Hilton London MetropoleThe conference42 million men, women and children worldwide were living with HIV by the end of December 2002 (source: UNAIDS), including five million newly-infected during that year alone. Another 45 million people will become infected between 2002 and 2010, unless the current transmission rates can be vastly reduced. Of the 42 million, 29.4 million live in sub-Saharan Africa and 58% of them are women. Not only are women more susceptible to HIV infection, many are powerless to insist on the use of condoms or other methods of protecting themselves. In this context, and with the knowledge that an effective HIV vaccine is unlikely to be available for several years, the need for an effective topical microbicide grows ever more urgent. 2004 should prove to be a landmark year in the field of microbicide development as the first Phase III trials of novel products are due to start – the next step along the road to making a microbicide available to the millions worldwide in desperate need of protection.The aims of the Microbicides 2004 conference are to:Report novel or innovative work in the microbicides fieldProvide updates on recent microbicides research, divided into three tracks: basic science, clinical science, and behavioural science (including public health and the microbicide marketplace)Provide a forum for the discussion of new developments in microbicide research including ethical, clinical, behavioural and methodological issuesPresent opportunities for knowledge-sharing between microbicide researchers, public-health workers and advocacy organisations.There will be an opening ceremony on the evening of Sunday 28 March at which politicians, policy makers and the international media are expected. The conference will run for a full three days, each of which will contain:Scientific overviews and presentations with plenary sessions, invited lecturers and presentations of original researchWorkshops to review issues unique to microbicides such as trial design and outcome measures, and ethical issues in the clinical trials of microbicidesPoster sessions. Focus on LondonFollowing the successful Microbicides conferences in Washington in 2000 and Antwerp in 2002, March 2004 sees the focus move to London.The venue is the Hilton Metropole Hotel, two minutes by taxi from Paddington station and the Heathrow Express, with a journey time from the airport of 15 minutes. The hotel is in walking distance of Hyde Park and London’s main shopping streets, and close to Imperial College. Accommodation will be available at the venue and other hotels in the vicinity.London in March offers a variety of diversions for out-of-conference relaxation, including sight-seeing and shopping; the arts and the theatre; and pubs, clubs and restaurants to suit every taste. Conference staff will be on hand to help delegates plan their spare time.To book your place or find out more information, e-mail info@microbicides2004.org.uk or telephone the Event Office on +44 (0) 20 7720 4411

02148 CHALLENGES IN CONDUCTING MICROBICIDE PREPAREDNESS STUDIES IN URBAN AND RURAL SOUTH AFRICA

02152 MICROBICIDES AND THE DEVELOPING WORLD: SOCIO-ECONOMIC AND ETHICAL CHALLENGES IN THE INDIAN CONTEXT

02158 MICROBICIDE TRIALS AND EDUCATION: STRATEGIES AND COMMUNITY PREPAREDNESS AT NIGERIAN OIL LOCATIONS

02244 WOMEN’S AUTONOMY AND INFORMED CONSENT IN MICROBICIDES CLINICAL TRIALS RESEARCH

02276 ENGAGING GAY MEN IN MICROBICIDE ADVOCACY

02284 MICROBICIDE FEASIBILITY STUDY, MWANZA, TANZANIA: PRIORITISING & RESPONDING TO COMMUNITY CONCERNS

02391_3 SEXUAL BARRIER METHOD ACCEPTABILITY AMOUNG HIV- POSITIVE US AND ZAMBIAN WOMEN

02405 NEW RESOURCES FOR THE FIELD: THE MICROBICIDE RESEARCH AND DEVELOPMENT DATABASE

02406 DETERMINING THE COST: GETTING TO PROOF OF CONCEPT

02462 DEVELOPMENT OF A RECRUITMENT VIDEO FOR A PHASE 3 TRIAL OF CARRAGUARD

02556 ADVOCATING FOR MICROBICIDES USING A SEXUAL RIGHTS FRAMEWORK: LESSONS FROM SOUTH AFRICA

02590 HOW IMPORTANT IS THE STI EFFICACY OF A MICROBICIDE: MODEL PREDICTIONS FROM TWO SETTINGS

02617 MICROBICIDE APPLICATOR RESEARCH FOR USE IN LOW-RESOURCE SETTINGS

02618_1 MEASURING DESIGN TRADE-OFFS FOR MICROBICIDE APPLICATORS IN THE DOMINICAN REPUBLIC AND SOUTH AFRICA

02638 DISCLOSURE OF STUDY PARTICIPATION AND HIV STATUS AMONG WOMEN IN A MICROBICIDE FEASIBILITY STUDY

02653 ADVOCATING FOR MICROBICIDES IN THE GLOBAL SOUTH: APPROACHES AND METHODS

02668 THE PROCESS OF FORMING A COMMUNITY ADVISORY GROUP: EXPERIENCES FROM A FEASIBILITY STUDY IN SOWETO

02669 IS HIV TESTING IN HIV PREVENTION TRIALS ACCEPTABLE? RESULTS FROM A STUDY IN SOWETO

02675 HOW RELIABLE DOES SELF-REPORTED SEX BEHAVIOUR NEED TO BE FOR VALID MICROBICIDE EFFICACY ESTIMATION?

02688 NIAID TOPICAL MICROBICIDE STRATEGIC PLAN: DISCOVERY, DEVELOPMENT AND EVALUATION

02694 HIV TREATMENTS, MICROBICIDES AND VACCINES: ADVANCING A RIGHTS-BASED AGENDA FOR RESEARCH, DEVELOPMENT AND ACCESS

02696 Projections of the resource requirements for promoting and distributing microbicides